Amber Dance in Nature:
First, the good news: I have 133 microbial species living in my gut. That’s a collection that ranks as ‘excellent’ according to NirvanaBiome, the company in Germantown, Maryland, that analysed my stool sample. The firm based its rating on the overall diversity of my gut’s residents plus my levels of specific beneficial and undesirable species. But then came a second, less promising assessment: Viome in Bellevue, Washington, identified only 61 kinds of active microorganism in my gut and suggested that some of them were not performing optimally. Viome recommended dietary changes and offered customized supplements to improve my health.
…Microbiologists and gasteroenterologists who spoke to Nature generally agreed that microbiome testing has the potential to both reflect and promote health, but many said that the science isn’t yet mature enough to support microbiome testing for most consumers. In their view, the limited clinical usefulness of today’s consumer tests can make them poor value for money (costing around US$100–300). The specialists warn that acting on advice that doesn’t come from clinicians could lead customers to adopt unnecessarily restrictive diets or delay appropriate medical assessment. Critics say that consumer microbiome testing needs more regulatory scrutiny and oversight.
More here.
Enjoying the content on 3QD? Help keep us going by donating now.
